These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 35845404)

  • 1. Recent Progress in Bio-Responsive Drug Delivery Systems for Tumor Therapy.
    Cong X; Chen J; Xu R
    Front Bioeng Biotechnol; 2022; 10():916952. PubMed ID: 35845404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advances in Metal-Organic Frameworks as Anticancer Drug Delivery Systems: A Review.
    Karami A; Mohamed O; Ahmed A; Husseini GA; Sabouni R
    Anticancer Agents Med Chem; 2021; 21(18):2487-2504. PubMed ID: 33463479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor microenvironment responsive drug delivery systems.
    He Q; Chen J; Yan J; Cai S; Xiong H; Liu Y; Peng D; Mo M; Liu Z
    Asian J Pharm Sci; 2020 Jul; 15(4):416-448. PubMed ID: 32952667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polysaccharide-based tumor microenvironment-responsive drug delivery systems for cancer therapy.
    Wu Q; Hu Y; Yu B; Hu H; Xu FJ
    J Control Release; 2023 Oct; 362():19-43. PubMed ID: 37579973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redox dual-stimuli responsive drug delivery systems for improving tumor-targeting ability and reducing adverse side effects.
    Li R; Peng F; Cai J; Yang D; Zhang P
    Asian J Pharm Sci; 2020 May; 15(3):311-325. PubMed ID: 32636949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimuli-responsive chitosan-based nanocarriers for cancer therapy.
    Fathi M; Sahandi Zangabad P; Majidi S; Barar J; Erfan-Niya H; Omidi Y
    Bioimpacts; 2017; 7(4):269-277. PubMed ID: 29435435
    [No Abstract]   [Full Text] [Related]  

  • 7. The Intracellular and Extracellular Microenvironment of Tumor Site: The Trigger of Stimuli-Responsive Drug Delivery Systems.
    Jing X; Hu H; Sun Y; Yu B; Cong H; Shen Y
    Small Methods; 2022 Mar; 6(3):e2101437. PubMed ID: 35048560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous stimuli-responsive linkers in nanoliposomal systems for cancer drug targeting.
    Faal Maleki M; Jafari A; Mirhadi E; Askarizadeh A; Golichenari B; Hadizadeh F; Jalilzadeh Moghimi SM; Aryan R; Mashreghi M; Jaafari MR
    Int J Pharm; 2019 Dec; 572():118716. PubMed ID: 31705978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in Multiple Stimuli-Responsive Drug-Delivery Systems for Cancer Therapy.
    Jia R; Teng L; Gao L; Su T; Fu L; Qiu Z; Bi Y
    Int J Nanomedicine; 2021; 16():1525-1551. PubMed ID: 33658782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimuli-responsive delivery vehicles based on mesoporous silica nanoparticles: recent advances and challenges.
    Zhu J; Niu Y; Li Y; Gong Y; Shi H; Huo Q; Liu Y; Xu Q
    J Mater Chem B; 2017 Feb; 5(7):1339-1352. PubMed ID: 32264626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic impacts of enzyme-responsive smart nanobiosystems.
    Fathi M; Safary A; Barar J
    Bioimpacts; 2020; 10(1):1-4. PubMed ID: 31988850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smart Stimuli-Responsive and Mitochondria Targeting Delivery in Cancer Therapy.
    Huang Y; Wang T; Tan Q; He D; Wu M; Fan J; Yang J; Zhong C; Li K; Zhang J
    Int J Nanomedicine; 2021; 16():4117-4146. PubMed ID: 34163163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound-controlled drug release and drug activation for cancer therapy.
    Tu L; Liao Z; Luo Z; Wu YL; Herrmann A; Huo S
    Exploration (Beijing); 2021 Dec; 1(3):20210023. PubMed ID: 37323693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimuli-responsive nano-assemblies for remotely controlled drug delivery.
    Li F; Qin Y; Lee J; Liao H; Wang N; Davis TP; Qiao R; Ling D
    J Control Release; 2020 Jun; 322():566-592. PubMed ID: 32276006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging nanotechnological approaches to regulating tumor vasculature for cancer therapy.
    Wang C; Xu J; Zhang Y; Nie G
    J Control Release; 2023 Oct; 362():647-666. PubMed ID: 37703928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Advances in pH- or/and Photo-Responsive Nanovehicles.
    Shin Y; Husni P; Kang K; Lee D; Lee S; Lee E; Youn Y; Oh K
    Pharmaceutics; 2021 May; 13(5):. PubMed ID: 34069233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ROS-responsive drug delivery systems.
    Liang J; Liu B
    Bioeng Transl Med; 2016 Sep; 1(3):239-251. PubMed ID: 29313015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in hyaluronic acid-based nanomedicines: Preparation and application in cancer therapy.
    Hou X; Zhong D; Chen H; Gu Z; Gong Q; Ma X; Zhang H; Zhu H; Luo K
    Carbohydr Polym; 2022 Sep; 292():119662. PubMed ID: 35725165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nano-Drug Delivery Systems in Oral Cancer Therapy: Recent Developments and Prospective.
    Zhang Y; Wu Y; Du H; Li Z; Bai X; Wu Y; Li H; Zhou M; Cao Y; Chen X
    Pharmaceutics; 2023 Dec; 16(1):. PubMed ID: 38276483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biopolymers for Antitumor Implantable Drug Delivery Systems: Recent Advances and Future Outlook.
    Talebian S; Foroughi J; Wade SJ; Vine KL; Dolatshahi-Pirouz A; Mehrali M; Conde J; Wallace GG
    Adv Mater; 2018 Aug; 30(31):e1706665. PubMed ID: 29756237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.